This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jacob Cole Deforest: Innovator in Pharmaceutical Compounds
Introduction
Jacob Cole Deforest is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrido[4,3-d]pyrimidine compounds. His research focuses on the development of compounds that have potential applications in medicine, especially in the treatment of various diseases.
Latest Patents
Jacob Cole Deforest holds 1 patent for his invention related to pyrido[4,3-d]pyrimidine compounds. This patent encompasses compounds of Formula (I)-(III) and their pharmaceutically acceptable salts. The invention details their use in medicine, compositions containing these compounds, processes for their preparation, and intermediates used in such processes. The compounds may be beneficial in treating, preventing, suppressing, and ameliorating diseases, disorders, and conditions such as cancers.
Career Highlights
Jacob is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer allows him to contribute to the development of innovative medical solutions that can improve patient outcomes. His expertise in pharmaceutical compounds has positioned him as a valuable asset in the industry.
Collaborations
Jacob has collaborated with notable colleagues, including Benjamin Joseph Burke and Asako Nagata. These collaborations have likely enhanced the research and development of his patented compounds, fostering a productive environment for innovation.
Conclusion
Jacob Cole Deforest is a distinguished inventor whose work in pharmaceutical compounds holds promise for advancing medical treatments. His contributions to the field exemplify the impact of innovation in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
